Buscar
Mostrando ítems 1-10 de 10
Diastolic dysfunction following anthracycline-based chemotherapy in breast cancer patients: incidence and predictors
(AlphaMed Press, 2015-07-16)
[Abstract] INTRODUCTION:
Cardiotoxicity represents a major limitation for the use of anthracyclines or trastuzumab in breast cancer patients. Data from longitudinal studies of diastolic dysfunction (DD) in this group ...
Sedation and analgesia practices among spanish neonatal intensive care units
(Elsevier, 2015-07-23)
[Abstract] Introduction. Pain management and sedation is a priority in neonatal intensive care units. A study was designed with the aim of determining current clinical practice as regards sedation and analgesia in neonatal ...
Prevalence of Stable Angina in Spain: results of the OFRECE Study
(Elsevier, 2015-02-17)
[Abstract] Introduction and objectives. The objective of the OFRECE study was to estimate the prevalence of stable angina in Spain. This prevalence is currently unknown, due to a lack of recent studies and to changes in ...
Organization of heart failure care in Spain: characteristics of heart failure units
(Elsevier, 2015-05-08)
Quality of anticoagulation with vitamin K antagonists
(Wiley, 2015-05-11)
[Abstract] Background. Vitamin K antagonists (VKA) have a narrow therapeutic range, and literature analysis reveals poor quality of anticoagulation control. We sought to assess the prevalence of poor anticoagulant control ...
Calidad de vida relacionada con la salud de los pacientes con insuficiencia cardiaca crónica sistólica en España: resultados del estudio VIDA-IC
(Elsevier, 2015-12-23)
[Resumen] Introducción y objetivos. La calidad de vida relacionada con la salud de los pacientes con insuficiencia cardiaca está afectada. Hay poca información sobre los factores clínicos asociados a esta mala calidad de ...
Choice of new oral anticoagulant agents versus vitamin K antagonists in atrial fibrillation: FANTASIIA study
(SAGE, 2015-07-30)
[Abstract] Introduction: Atrial fibrillation (AF) is associated with an increased risk of thromboembolic events. Many patients with AF receive chronic anticoagulation, either with vitamin K antagonists (VKAs) or with non-VKA ...